Skip to main content
search
All Posts By

Dawn

Membership NewsMembership News Archive

Labour Conference Roundup

This week saw Labour’s 2023 Conference in Liverpool, and with the opposition riding high in the polls, we paid close attention to their comments on health and technology. Much like the Conservative Conference, health policy was often focused on prevention, with Labour also focusing on how the health and wealth of the nation are inextricably linked. The Shadow Health Secretary…
Dawn
October 13, 2023
Membership NewsMembership News Archive

Paul Fisher joins BIVDA as Head of Policy, Programmes, and Compliance

We are delighted to announce that Paul Fisher has joined BIVDA as Head of Policy, Programmes, and Compliance after a 25-year career in the public and private sector. Most recently, Paul was a senior Civil Servant with the UK Health Security Agency and the Department of Health and Social Care, specialising in the delivery of significant government health programmes. At…
Dawn
October 13, 2023
ConsultationsConsultations Archive

ISO/NP 23421 Medical devices — Terminology — Terms used in the field of quality management and corresponding general aspects for products with a health purpose including medical devices

You can access the consultation here. Comment period end date: 03/11/2023 Scope This document defines terms in the field of quality management and corresponding general aspects for products with a health purpose including medical devices. Purpose This document will provide the fundamental terminology used in quality management and the corresponding general aspects for products with a health purpose including medical…
Dawn
October 6, 2023
ConsultationsConsultations Archive

ISO/NP TS 23918 Medical devices — Guidance on the application of ISO 14971 — Part 2: Machine learning in artificial intelligence

You can access the consultation here. Comment period end date: 08/10/2023 Scope This document provides guidance for applying an ISO 14971 risk management process when evaluating medical technology utilizing machine learning (ML). It is intended to apply to ML-enabled medical devices throughout all phases of the product lifecycle. This document is intended to be used in conjunction with ISO 14971.…
Dawn
October 6, 2023
HighlightsHighlights Archive

Media Monitoring: 30 September – 6 October

New £60 million Regional Innovation Fund among measures to boost research and development DSIT Secretary Michell Donelan has announced A £60 million Regional Innovation Fund (RIF) that will boost support for universities in areas with lower levels of research and development investment Over 110 universities to benefit from pilot Regional Innovation Fund (RIF) to grow local economies An extra £8…
Dawn
October 6, 2023
HighlightsHighlights Archive

Genomics England announces the rare conditions included in world-leading research study

Genomics England have published an initial list of over 200 rare conditions that will be looked for as part of its world-leading Generation Study, which aims to start in NHS hospitals in late 2023. The Generation Study is an NHS-embedded research study which aims to understand whether sequencing babies’ genomes can help to discover rare genetic conditions earlier. It aims to…
Dawn
October 6, 2023
HighlightsHighlights Archive

Government to invest £30 million in innovative technology for NHS

Patients across the country will benefit from a £30 million government investment in innovative medical technology which will help ease pressures on the NHS this winter and could include the expansion of 3D checks that speed up cancer tests. Available to each region in England, ICSs - organisations that come together in local areas to deliver joined up health and social care services…
Dawn
October 6, 2023
Membership NewsMembership News Archive

Reminder: consultation feedback for ‘The disclosure of industry payments to the healthcare sector’

Consultation description DHSC seek views on the possible introduction of new secondary legislation to place a duty on manufacturers and commercial suppliers of medicines, devices and borderline substances to report details of the payments and other benefits they provide to healthcare professionals and organisations. This consultation aims to address the second part of recommendation 8 contained in the Independent Medicines and…
Dawn
October 6, 2023
Close Menu